Product Information
DOXEPIN 10 MG/ML ORAL CONC is a generic product labeled by Lannett Company Inc., priced at $0.8388 per ML under NDC 54838051240. Its NADAC has been published 511 times since Nov 28, 2013.
FDA first approved this application on Dec 29, 1998.
Strength
10 mg/mL
Manufacturer
Lannett Company Inc.NDC
54838051240
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074721FDA Approved
12/29/1998
On Market Since
12/29/1998
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 10 MG/ML ORAL CONC has been published 511 times since Nov 28, 2013, and over the history we have for it it has risen 1275.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8388 per ML |
|---|---|
| All-time high | $0.9767 (Jun 10, 2026) |
| All-time low | $0.0411 (Apr 23, 2014) |
| 52-week high | $0.9767 |
| 52-week low | $0.4047 |
| Median price | $0.2647 |
| Average price | $0.2508 |
| Largest weekly change | +173.6% (Dec 18, 2019) |
| Weeks tracked | 511 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Doxepin Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxepin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXEPIN 10 MG/ML ORAL CONC?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 10 MG/ML ORAL CONC, manufactured by Lannett Company Inc., is $0.8388 per ML (NDC 54838051240), effective Sep 30, 2026.
How has the price of DOXEPIN 10 MG/ML ORAL CONC changed over time?
Over the history we have for it, the NADAC for DOXEPIN 10 MG/ML ORAL CONC has risen 1275.8%. It has been tracked across 511 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DOXEPIN 10 MG/ML ORAL CONC?
Since Nov 28, 2013, the NADAC for DOXEPIN 10 MG/ML ORAL CONC has ranged from a low of $0.0411 (Apr 23, 2014) to a high of $0.9767 (Jun 10, 2026), with a median of $0.2647 per ML.
Are there cheaper alternatives to DOXEPIN 10 MG/ML ORAL CONC?
No other NADAC-published product currently shares the active ingredient and strength of DOXEPIN 10 MG/ML ORAL CONC in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXEPIN 10 MG/ML ORAL CONC?
DOXEPIN 10 MG/ML ORAL CONC (NDC 54838051240) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.